interleukin-1beta (163-171) has been researched along with Seizures in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, I; Amhaoul, H; Bhattacharya, A; Bielen, K; Ceusters, M; Dedeurwaerdere, S; Kumar-Singh, S; Lord, B; Missault, S; Mola, M; Rech, J; Szewczyk, K; Van Eetveldt, A | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and Seizures
| Article | Year |
|---|---|
P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy.
Topics: Animals; Brain; Disease Models, Animal; Encephalitis; Epilepsy, Temporal Lobe; Gliosis; Interleukin-1beta; Isoquinolines; Microglia; Peptide Fragments; Piperazines; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Seizures; Status Epilepticus | 2016 |